RNA-Gain-of-Function Pathogenesis in SCA10
SCA10 中 RNA 功能获得的发病机制
基本信息
- 批准号:8557439
- 负责人:
- 金额:$ 32.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-05-01 至 2018-01-31
- 项目状态:已结题
- 来源:
- 关键词:Alternative SplicingApoptosisApoptoticAutopsyBehaviorBindingBioinformaticsBiological AssayBrainCell Culture TechniquesCell DeathCell SurvivalCellsCerebellar AtaxiaChromosomesCo-ImmunoprecipitationsComputer SimulationCultured CellsDataDiseaseEpilepsyEventFamilyFibroblastsFluorescent in Situ HybridizationFutureGenesGeneticGoalsHeterogeneous-Nuclear Ribonucleoprotein KHumanIn VitroIndividualIntronsKnockout MiceKnowledgeMass Spectrum AnalysisMediatingMessenger RNAMicrosatellite RepeatsMitochondriaModelingMotorMusMutationNeurodegenerative DisordersNeurologicNeuronal DysfunctionNeuronsPC12 CellsPathogenesisPathogenicityPathway interactionsPatientsPentanucleotide RepeatsPhenotypePlayProcessProteinsRNARNA SplicingRNA-Binding ProteinsRelative (related person)Research PersonnelRoleSmall Interfering RNASodium ChlorideSpinocerebellar AtaxiasTranscriptTransgenic MiceUntranslated RNAWestern BlottingWild Type Mouseadeno-associated viral vectorbrain cellcaspase-3clinical phenotypecrosslinkfunctional lossgain of functionhigh throughput screeningin vivoinduced pluripotent stem cellinterestloss of functionmembermouse modelmutantnervous system disorderprotein functionprotein kinase C-deltaprototypepublic health relevancesolutetherapeutic developmenttherapeutic targettranslational study
项目摘要
DESCRIPTION (provided by applicant): Spinocerebellar ataxia type 10 (SCA10), an autosomal dominant cerebellar ataxia, is caused by a large expansion mutation of intronic ATTCT pentanucleotide repeat in the ATXN10 gene. Our studies have suggested that toxic RNA rather than altered function of the protein product of ATXN10 is the likely cause of SCA10. We showed that the untranslated RNA transcript of the expanded repeat is accumulated in intracellular foci and interacts with heterogeneous nuclear ribonucleoprotein K (hnRNP K). Preliminary data from cell culture and transgenic mouse models suggested that expression of (AUUCU) 500 repeats causes deleterious downstream events similar to those seen in cells and a brain of SCA10 patient. Knockdown of hnRNP K recapitulates some of these events in cell culture. The goal of this application is to demonstrate that the sequestration of hnRNP K plays a key role in SCA10 pathogenesis and to determine the relative contribution of this mechanism to the entire pathogenicity in SCA10. Our central hypothesis is that the major pathogenic mechanism of SCA10 is an RNA gain-of-function that causes functional loss of hnRNP K. To examine this hypothesis we propose: ? Aim 1: Demonstrate binding of the expanded AUUCU repeat RNA to hnRNP K. We will perform unbiased searches of interacting proteins by pull-down/mass spectroscopy studies and in-silico bioinformatics, followed by co-immunoprecipitation, electromobility shift assay and high-throughput crosslinking studies. ? Aim 2: Obtain evidence that hnRNP K sequestration causes neuronal dysfunction and cell death. We will recapitulate downstream changes found in the SCA10 brain and SCA10 models, such as activation of apoptotic pathways and abnormal alternative splicing of a variety of transcripts, by knockdown of hnRNP K in wild-type mice and cell cultures including neural cells derived from induced pluripotent stem (iPS) cells. ? Aim 3: Determine the relative contribution of hnRNP K to the SCA10 pathogenicity by examining the degree of rescue achieved by over-expression of hnRNP K in cell culture and transgenic mouse models. These studies will firmly establish the pathogenic role of hnRNP K and provide a therapeutic target.
描述(由申请人提供):脊髓脑性共济失调类型10(SCA10)是一种常染色体显性小脑共济失调,是由ATXN10基因中内含子AttCT pentanucleotide重复的大膨胀突变引起的。我们的研究表明,ATXN10蛋白产物的毒性RNA而不是改变的功能是SCA10的原因。我们表明,扩展的重复的未翻译RNA转录本在细胞内灶中累积,并与异质的核核糖核蛋白K(HNRNP K)相互作用。来自细胞培养和转基因小鼠模型的初步数据表明,(AUUCU)500重复的表达会导致有害的下游事件,类似于细胞中的细胞和SCA10患者的大脑。 HNRNP K的敲低概括了细胞培养中的一些事件。该应用的目的是证明HNRNP k的隔离在SCA10发病机理中起关键作用,并确定该机制对SCA10中整个致病性的相对贡献。我们的中心假设是SCA10的主要致病机制是RNA功能获得的功能,它导致HNRNP K的功能丢失。检查我们提出的这一假设:? AIM 1:证明了扩展的AUUCU重复RNA与HNRNP K的结合。我们将通过下拉/质谱研究和silico Inilico生物信息学对相互作用的蛋白质进行无偏见的搜索,然后进行共免疫沉淀,电动性转移分析和高电流交叉互换研究。 ?目的2:获得HNRNP K隔离会导致神经元功能障碍和细胞死亡的证据。我们将通过敲低野生型小鼠中的HNRNP K敲低HNRNP K来概括SCA10脑和SCA10模型中发现的下游变化,例如凋亡途径的激活以及各种转录本的异常替代剪接。 ? AIM 3:通过检查HNRNP K在细胞培养和转基因小鼠模型中过度表达实现的救援程度,确定HNRNP K对SCA10致病性的相对贡献。这些研究将牢固确定HNRNP K的致病作用,并提供治疗靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TETSUO ASHIZAWA其他文献
TETSUO ASHIZAWA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TETSUO ASHIZAWA', 18)}}的其他基金
Supplementary funding for U01NS104326 Clinical Trial Readiness for SCA1 and SCA3 (“READISCA”)
U01NS104326 SCA1 和 SCA3 临床试验准备的补充资金 (–READISCA–)
- 批准号:
10623060 - 财政年份:2022
- 资助金额:
$ 32.32万 - 项目类别:
Genetic mechanism of conserved ancestral haplotype in SCA10
SCA10保守祖先单倍型的遗传机制
- 批准号:
9890198 - 财政年份:2019
- 资助金额:
$ 32.32万 - 项目类别:
Genetic mechanism of conserved ancestral haplotype in SCA10
SCA10保守祖先单倍型的遗传机制
- 批准号:
10545044 - 财政年份:2019
- 资助金额:
$ 32.32万 - 项目类别:
Genetic mechanism of conserved ancestral haplotype in SCA10
SCA10保守祖先单倍型的遗传机制
- 批准号:
10093170 - 财政年份:2019
- 资助金额:
$ 32.32万 - 项目类别:
Clinical Trial Readiness for SCA1 and SCA3
SCA1 和 SCA3 的临床试验准备情况
- 批准号:
10091534 - 财政年份:2018
- 资助金额:
$ 32.32万 - 项目类别:
Clinical Trial Readiness for SCA1 and SCA3
SCA1 和 SCA3 的临床试验准备情况
- 批准号:
9438347 - 财政年份:2018
- 资助金额:
$ 32.32万 - 项目类别:
Clinical Trial Readiness for SCA1 and SCA3
SCA1 和 SCA3 的临床试验准备情况
- 批准号:
10327685 - 财政年份:2018
- 资助金额:
$ 32.32万 - 项目类别:
RNA-Gain-of-Function Pathogenesis in SCA10
SCA10 中 RNA 功能获得的发病机制
- 批准号:
8793081 - 财政年份:2013
- 资助金额:
$ 32.32万 - 项目类别:
Clinical Research Consortium for Spinocerebellar Ataxias
脊髓小脑性共济失调临床研究联盟
- 批准号:
7839369 - 财政年份:2009
- 资助金额:
$ 32.32万 - 项目类别:
相似国自然基金
HIF-2α介导Müller调节神经细胞凋亡的缺血性视网膜病变机制研究
- 批准号:82371077
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
草鱼贮藏过程肌细胞凋亡对鱼肉品质的影响机制研究
- 批准号:32372397
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
RIG-I/MAVS非干扰素依赖通路诱导细胞凋亡介导七鳃鳗抗病毒的机制研究
- 批准号:32360150
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
SLC46A3参与铜耗竭介导的mPFC抑制性神经元坏死性凋亡在睡眠剥夺致术后痛慢性化的机制研究
- 批准号:82371235
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
银鲳磷酸酶A2抑制因子(PLI)对水母毒素诱导细胞凋亡的抑制作用及机制研究
- 批准号:42306114
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Mechanism of cell lethality following loss of gene expression.
基因表达缺失后细胞致死的机制。
- 批准号:
10751723 - 财政年份:2023
- 资助金额:
$ 32.32万 - 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
- 批准号:
10735148 - 财政年份:2023
- 资助金额:
$ 32.32万 - 项目类别:
Targeting Acid Ceramidase and Bcl-2 in Acute Myeloid Leukemia
靶向酸性神经酰胺酶和 Bcl-2 治疗急性髓系白血病
- 批准号:
10651649 - 财政年份:2022
- 资助金额:
$ 32.32万 - 项目类别:
Alleviation of Glucotoxicity in Pancreatic Beta Cells
减轻胰腺β细胞的糖毒性
- 批准号:
10316752 - 财政年份:2021
- 资助金额:
$ 32.32万 - 项目类别:
Alleviation of Glucotoxicity in Pancreatic Beta Cells
减轻胰腺β细胞的糖毒性
- 批准号:
10643853 - 财政年份:2021
- 资助金额:
$ 32.32万 - 项目类别: